{"id":"https://openalex.org/W2889633769","doi":"https://doi.org/10.14283/jpad.2018.30","title":"Pimavanserin in Alzheimer's Disease Psychosis: Efficacy in Patients with More Pronounced Psychotic Symptoms","display_name":"Pimavanserin in Alzheimer's Disease Psychosis: Efficacy in Patients with More Pronounced Psychotic Symptoms","publication_year":2019,"publication_date":"2019-01-01","ids":{"openalex":"https://openalex.org/W2889633769","doi":"https://doi.org/10.14283/jpad.2018.30","mag":"2889633769","pmid":"https://pubmed.ncbi.nlm.nih.gov/30569083","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12280763"},"language":"en","primary_location":{"id":"doi:10.14283/jpad.2018.30","doi":"https://doi.org/10.14283/jpad.2018.30","is_oa":true,"landing_page_url":"https://doi.org/10.14283/jpad.2018.30","pdf_url":"https://link.springer.com/content/pdf/10.14283/jpad.2018.30.pdf","source":{"id":"https://openalex.org/S4210234663","display_name":"The Journal of Prevention of Alzheimer s Disease","issn_l":"2274-5807","issn":["2274-5807","2426-0266"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Prevention of Alzheimer's Disease","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://link.springer.com/content/pdf/10.14283/jpad.2018.30.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032708452","display_name":"Clive G. Ballard","orcid":"https://orcid.org/0000-0003-0022-5632","observed_orcids":["https://orcid.org/0000-0003-0022-5632"]},"institutions":[{"id":"https://openalex.org/I23923803","display_name":"University of Exeter","ror":"https://ror.org/03yghzc09","country_code":"GB","type":"education","lineage":["https://openalex.org/I23923803"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Clive Ballard","raw_affiliation_strings":["Clive Ballard, MBChB, Institute of Health Research, University of Exeter Medical School, Exeter EX1 2LU, UK, C.Ballard@exeter.ac.uk","Institute of Health Research, University of Exeter Medical School, Exeter, EX1 2LU, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clive Ballard, MBChB, Institute of Health Research, University of Exeter Medical School, Exeter EX1 2LU, UK, C.Ballard@exeter.ac.uk","institution_ids":["https://openalex.org/I23923803"]},{"raw_affiliation_string":"Institute of Health Research, University of Exeter Medical School, Exeter, EX1 2LU, UK","institution_ids":["https://openalex.org/I23923803"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087611468","display_name":"James M. Youakim","orcid":"https://orcid.org/0000-0001-5551-8956","observed_orcids":["https://orcid.org/0000-0001-5551-8956"]},"institutions":[{"id":"https://openalex.org/I125377440","display_name":"Acadia Pharmaceuticals (United States)","ror":"https://ror.org/030bhbq32","country_code":"US","type":"company","lineage":["https://openalex.org/I125377440"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J.M. Youakim","raw_affiliation_strings":["ACADIA Pharmaceuticals Inc., San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ACADIA Pharmaceuticals Inc., San Diego, CA, USA","institution_ids":["https://openalex.org/I125377440"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067365646","display_name":"Bruce Coate","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I125377440","display_name":"Acadia Pharmaceuticals (United States)","ror":"https://ror.org/030bhbq32","country_code":"US","type":"company","lineage":["https://openalex.org/I125377440"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B. Coate","raw_affiliation_strings":["ACADIA Pharmaceuticals Inc., San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ACADIA Pharmaceuticals Inc., San Diego, CA, USA","institution_ids":["https://openalex.org/I125377440"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004670943","display_name":"Srdjan Stankovic","orcid":"https://orcid.org/0000-0003-3668-6529","observed_orcids":["https://orcid.org/0000-0003-3668-6529","https://orcid.org/0000-0003-4679-2130"]},"institutions":[{"id":"https://openalex.org/I125377440","display_name":"Acadia Pharmaceuticals (United States)","ror":"https://ror.org/030bhbq32","country_code":"US","type":"company","lineage":["https://openalex.org/I125377440"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Stankovic","raw_affiliation_strings":["ACADIA Pharmaceuticals Inc., San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ACADIA Pharmaceuticals Inc., San Diego, CA, USA","institution_ids":["https://openalex.org/I125377440"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5032708452"],"corresponding_institution_ids":["https://openalex.org/I23923803"],"apc_list":{"value":1990,"currency":"USD","value_usd":1990},"apc_paid":{"value":1990,"currency":"USD","value_usd":1990},"fwci":4.0111,"has_fulltext":true,"cited_by_count":41,"citation_normalized_percentile":{"value":0.93899061,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"6","issue":"1","first_page":"27","last_page":"33"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.8661999702453613,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.8661999702453613,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.06599999964237213,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.04190000146627426,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pimavanserin","display_name":"pimavanserin","score":1.0},{"id":"https://openalex.org/keywords/5-ht2a-receptor-antagonist","display_name":"5-HT2A receptor antagonist","score":0.8799999952316284},{"id":"https://openalex.org/keywords/inverse-agonists","display_name":"inverse agonists","score":0.7360000014305115},{"id":"https://openalex.org/keywords/nursing-home-residents","display_name":"nursing home residents","score":0.9200000166893005},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.7369999885559082},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.8510000109672546},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7649999856948853},{"id":"https://openalex.org/keywords/urinary-tract-infection","display_name":"urinary tract infection","score":0.8379999995231628},{"id":"https://openalex.org/keywords/falls","display_name":"falls","score":0.4650000035762787}],"concepts":[{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7990046739578247},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.7103293538093567},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.565994381904602},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.562943696975708},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5397689342498779},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5397539734840393},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4829096794128418},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4475763142108917},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3569537401199341},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3302549719810486},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.20961517095565796},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.11276400089263916},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009735","descriptor_name":"Nursing Homes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014508","descriptor_name":"Urea","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014508","descriptor_name":"Urea","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D014508","descriptor_name":"Urea","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058830","descriptor_name":"Serotonin 5-HT2 Receptor Antagonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D058830","descriptor_name":"Serotonin 5-HT2 Receptor Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.14283/jpad.2018.30","doi":"https://doi.org/10.14283/jpad.2018.30","is_oa":true,"landing_page_url":"https://doi.org/10.14283/jpad.2018.30","pdf_url":"https://link.springer.com/content/pdf/10.14283/jpad.2018.30.pdf","source":{"id":"https://openalex.org/S4210234663","display_name":"The Journal of Prevention of Alzheimer s Disease","issn_l":"2274-5807","issn":["2274-5807","2426-0266"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Prevention of Alzheimer's Disease","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:11092526","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/12280763","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:12280763","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/12280763","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Prev Alzheimers Dis","raw_type":"Text"},{"id":"pmid:30569083","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30569083","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The journal of prevention of Alzheimer's disease","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:rde.dspace-express.com:11287/621653","doi":null,"is_oa":true,"landing_page_url":"https://rde.dspace-express.com/handle/11287/621653","pdf_url":null,"source":{"id":"https://openalex.org/S4306401891","display_name":"Royal Devon and Exeter Research Repository (Royal Devon and Exeter)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801242002","host_organization_name":"Royal Devon and Exeter Hospital","host_organization_lineage":["https://openalex.org/I2801242002"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.14283/jpad.2018.30","doi":"https://doi.org/10.14283/jpad.2018.30","is_oa":true,"landing_page_url":"https://doi.org/10.14283/jpad.2018.30","pdf_url":"https://link.springer.com/content/pdf/10.14283/jpad.2018.30.pdf","source":{"id":"https://openalex.org/S4210234663","display_name":"The Journal of Prevention of Alzheimer s Disease","issn_l":"2274-5807","issn":["2274-5807","2426-0266"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Prevention of Alzheimer's Disease","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320315029","display_name":"ACADIA Pharmaceuticals","ror":"https://ror.org/030bhbq32"},{"id":"https://openalex.org/F4320327918","display_name":"H. Lundbeck A/S","ror":"https://ror.org/0564cd633"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2889633769.pdf","grobid_xml":"https://content.openalex.org/works/W2889633769.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W1164896577","https://openalex.org/W1702828780","https://openalex.org/W1785160854","https://openalex.org/W1847168837","https://openalex.org/W1968565337","https://openalex.org/W1972294144","https://openalex.org/W1978322988","https://openalex.org/W1992109356","https://openalex.org/W1996776294","https://openalex.org/W2038799193","https://openalex.org/W2049349113","https://openalex.org/W2072303299","https://openalex.org/W2083705495","https://openalex.org/W2088317481","https://openalex.org/W2091570747","https://openalex.org/W2107881620","https://openalex.org/W2111963393","https://openalex.org/W2115235249","https://openalex.org/W2126128851","https://openalex.org/W2132592055","https://openalex.org/W2150063374","https://openalex.org/W2156220037","https://openalex.org/W2163049274","https://openalex.org/W2166643169","https://openalex.org/W2329608271","https://openalex.org/W2333793022","https://openalex.org/W2430732460","https://openalex.org/W2468352757","https://openalex.org/W2596981031","https://openalex.org/W2771987742","https://openalex.org/W2786029268","https://openalex.org/W4254703930"],"related_works":["https://openalex.org/W2897122286","https://openalex.org/W4291168566","https://openalex.org/W2786029268","https://openalex.org/W4416872847","https://openalex.org/W4386252145","https://openalex.org/W2889655735","https://openalex.org/W3046223064","https://openalex.org/W2787735479","https://openalex.org/W3136527843","https://openalex.org/W2921076905"],"abstract_inverted_index":{"BACKGROUND:":[0],"Pimavanserin":[1,58,224],"is":[2,9],"a":[3],"5-HT2A":[4],"receptor":[5],"inverse":[6],"agonist/antagonist":[7],"and":[8,20,98,141,149,159,177,182,194],"approved":[10],"in":[11,37,96,168,228,231],"the":[12,16,29,80,89,93,99,169,216],"United":[13],"States":[14],"for":[15,64,157,215],"treatment":[17,133,175],"of":[18,31,35,164,237],"hallucinations":[19],"delusions":[21],"associated":[22],"with":[23,39,54,104,191,197,203,233,243],"Parkinson's":[24],"disease":[25,41],"psychosis.":[26,56],"OBJECTIVE:":[27],"Evaluate":[28],"efficacy":[30,227],"pimavanserin":[32,158,192,204,244],"on":[33,79],"symptoms":[34,239],"psychosis":[36,85,230],"patients":[38,113,232],"Alzheimer's":[40],"(AD).":[42],"DESIGN:":[43],"Randomized,":[44],"double-blind,":[45],"placebo-controlled":[46],"trial.":[47],"SETTING:":[48],"Nursing":[49],"home":[50],"residents.":[51],"PARTICIPANTS:":[52],"Patients":[53],"AD":[55,229],"INTERVENTIONS:":[57],"34":[59],"mg":[60],"or":[61],"placebo":[62,195,208],"daily":[63],"12":[65,221],"weeks.":[66,222],"MEASUREMENTS:":[67],"The":[68,162],"primary":[69],"endpoint":[70],"was":[71,144,152,172,189],"mean":[72,94,217],"change":[73,95,211],"from":[74,212],"baseline":[75,105,121,213,235],"at":[76],"Week":[77],"6":[78],"Neuropsychiatric":[81],"Inventory-Nursing":[82],"Home":[83],"Version":[84],"score":[86,219],"(NPI-NH-PS).":[87],"In":[88,128],"prespecified":[90],"subgroup":[91,171],"analysis,":[92],"NPI-NH-PS":[97,106,122],"responder":[100],"rates":[101],"among":[102],"those":[103],"\u226512":[107,123],"were":[108,135,184],"evaluated.":[109],"RESULTS:":[110],"Of":[111],"181":[112],"randomized":[114],"(n=90":[115],"pimavanserin;":[116,125],"n=91":[117],"placebo),":[118],"57":[119],"had":[120],"(n=27":[124],"n=30":[126],"placebo).":[127],"this":[129],"severe":[130,170],"subgroup,":[131],"large":[132],"effects":[134],"observed":[136],"(delta=-4.43,":[137],"Cohen's":[138],"d=-0.73,":[139],"p=0.011),":[140],"\u226530%":[142],"improvement":[143,151],"88.9%":[145],"vs.":[146,154],"43.3%":[147,155],"(p<0.001)":[148],"\u226550%":[150],"77.8%":[153],"(p=0.008)":[156],"placebo,":[160],"respectively.":[161],"rate":[163],"adverse":[165],"events":[166],"(AEs)":[167],"similar":[173,190],"between":[174],"groups,":[176],"urinary":[178],"tract":[179],"infection,":[180],"fall,":[181],"agitation":[183],"most":[185],"frequent.":[186],"Serious":[187],"AEs":[188,202],"(17.9%)":[193],"(16.7%)":[196],"fewer":[198],"discontinuations":[199],"due":[200],"to":[201,207],"(7.1%)":[205],"compared":[206],"(10.0%).":[209],"Minimal":[210],"occurred":[214],"MMSE":[218],"over":[220],"CONCLUSIONS:":[223],"demonstrated":[225],"significant":[226],"higher":[234],"severity":[236],"psychotic":[238],"(NPI-NH-PS":[240],"\u226512).":[241],"Treatment":[242],"showed":[245],"an":[246],"acceptable":[247],"tolerability":[248],"profile.":[249]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":8},{"year":2018,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2018-09-27T00:00:00"}
